Newmanbrain 2024 Silver Winner Product Design Awards
Newmanbrain, winner of the international “NY Product Design Awards” Previous slide Next slide The spin-off Newmanbrain of the UMH Science Park has recently been recognized at the international awards “NY Product Design Award“. Specifically, these awards have distinguished the packaging design of the innovative brain diagnostic system developed by this company, called THEIA™. It is […]
Brain Awareness Week 2024
DEVICES THAT HELP US:
ARTIFICIAL INTELLIGENCE AND NEUROSCIENCES MEET
Chemostart VII Edition
ChemoStart is a global program of Insud Pharma that helps boost startups and companies with innovative projects in health and healthcare.
VI International Congress on Artificial Intelligence
Pablo Belmonte, CEO of Newmanbrain, participated in the VI International Congress on Artificial Intelligence during the discussion “AI IN HEALTH: ADVANCES AND RIGHTS”.
The disruption of Artificial Intelligence
The city of Valencia will host one of the main events in the field of innovation at European level, the Valencia Digital Summit 2023. This event will bring together the entire ecosystem of innovation in health and will serve to discuss its future and the most disruptive solutions.
NeurotechEU Technological and Societal Innovation Summit
Between October 2 and 5, individuals involved in NeurotechEU are gathering to discuss innovations in Technology and Society and to create a roadmap on NeurotechEU’s eight dimensions of neurotechnology.
11th IBRO World Congress of Neuroscience
IBRO and the Spanish Neuroscience Society (SENC, Sociedad Española de Neurociencia)
are excited to announce that the 11th IBRO World Congress of Neuroscience will be
hosted by SENC at the Granada Exhibition and Conference Centre
Alicante companies receive the keys to adapt to the high speed imposed by technology
Pablo Belmonte, Newmanbrain CEO, shares a discussion table in the edition of “SOFTING TIC&TALK” of ITI that is held in Alicante.
Early detection of MCI and fNIRs technology
MCI or Mild Cognitive Impairment, is a condition in which patients experiment a cognitive decline that is greater than what is expected for their age and education level. Having MCI does not necessary lead to dementia. However, individuals that present MCI, are more likely to develop a dementia than those who do not present this […]
THEIA™ Wins Prestigious Design Award
We are thrilled to announce that our latest fNIRs device, THEIA™, has been awarded an iF Design Award 2023.